Palliative care 2016
SUMMARY 2
MSCC
RS / SBRT
conv.
RT
Improvement, less selected:
23%
40%
Improvement, myeloma:
71%
76%
Improvement, ambulatory:
63%
62%
Potential Benefit of RS / SBRT for:
► Long-term Survivors (SBRT instead of RS to reduce late toxicity)
► Less Radiosensitive Tumors
► Re-RT, in particular after previous longer-course RT
Made with FlippingBook